Managing Side Effects and Staying the Course Some patients may experience side effects while taking semaglutide, especially during the initial stages of treatment
For cirrhosis (F4), it has an AUROC of 0.783, Sn 91.4%, specificity (Sp) 79.3%, PPV 93.3%, and a negative predictive value of 47.9%
Peptide solutions are sensitive to pH changes, and even small shifts can trigger conformational changes that reduce potency
Written by Heather Krawsek, RDN Reviewed by Carrie Weitzel, registered dietitian
Liraglutide, a GLP-1 receptor agonist, improves weight and glycaemic control in patients with T2DM
doi: 10.1111/j.1360-0443.2012.04054.x 11 McPheetersMOConnorEARileySKennedyS